Evidence map›Paper›PMID 33833328›Full record

ArticleScientific reports2021

Identification of critical amino acid residues in the regulatory N-terminal domain of PMEL.

Susan M Mitchell, Morven Graham, Xinran Liu, Ralf M Leonhardt

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Agouti and BMP signaling drive a naturally occurring fate conversion of melanophores to leucophores in zebrafish.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Susan M Mitchell *Department of Immunobiology, Yale University School of Medicine, 300 Cedar Street, New Haven, CT, 06519, USA.
Morven Graham *Department of Cell Biology, Yale University School of Medicine, 300 Cedar Street, New Haven, CT, 06519, USA.
Xinran LiuDepartment of Cell Biology, Yale University School of Medicine, 300 Cedar Street, New Haven, CT, 06519, USA.
Ralf M LeonhardtDepartment of Immunobiology, Yale University School of Medicine, 300 Cedar Street, New Haven, CT, 06519, USA. Ralf.Leonhardt@boehringer-ingelheim.com.

Funding

Mechanism of amyloid formation during melanosome biogenesisR21AR068518 · NIAMS · YALE UNIVERSITY · PI LEONHARDT, RALF MAX · 2016 to 2017
$405k
NIAMS NIH HHS R21 AR068518
6 · The paper itself

Abstract

The pigment cell-specific protein PMEL forms a functional amyloid matrix in melanosomes onto which the pigment melanin is deposited. The amyloid core consists of a short proteolytic fragment, which we have termed the core-amyloid fragment (CAF) and perhaps additional parts of the protein, such as the PKD domain. A highly O-glycosylated repeat (RPT) domain also derived from PMEL proteolysis associates with the amyloid and is necessary to establish the sheet-like morphology of the assemblies. Excluded from the aggregate is the regulatory N-terminus, which nevertheless must be linked in cis to the CAF in order to drive amyloid formation. The domain is then likely cleaved away immediately before, during, or immediately after the incorporation of a new CAF subunit into the nascent amyloid. We had previously identified a 21 amino acid long region, which mediates the regulatory activity of the N-terminus towards the CAF. However, many mutations in the respective segment caused misfolding and/or blocked PMEL export from the endoplasmic reticulum, leaving their phenotype hard to interpret. Here, we employ a saturating mutagenesis approach targeting the motif at single amino acid resolution. Our results confirm the critical nature of the PMEL N-terminal region and identify several residues essential for PMEL amyloidogenesis.

Indexed as

Protein DomainsAmino AcidsAmino Acid SequenceEndoplasmic Reticulumgp100 Melanoma AntigenHumansMelanosomesMutationProtein FoldingProtein TransportSubcellular FractionsAmino Acidsgp100 Melanoma AntigenPMEL protein, human

Identifiers

PMID33833328
PMCPMC8032716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.